Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-05-26 Option Award | 2023-05-31 5:34 pm | N/A 2030-05-25 | DYNAVAX TECHNOLOGIES CORP | DVAX | Sun Elaine D Director | 27,857 | $0 | 41,250 (Direct) | View |
| 2022-05-26 Option Award | 2022-05-27 5:01 pm | N/A N/A | DYNAVAX TECHNOLOGIES CORP | DVAX | Sun Elaine D Director | 13,929 | $0 | 13,929 (Direct) | View |
| 2021-12-10 Option Award | 2021-12-14 7:23 pm | N/A N/A | DYNAVAX TECHNOLOGIES CORP | DVAX | Sun Elaine D Director | 55,714 | $0 | 55,714 (Direct) | View |
Ownership | 2021-12-14 5:04 pm | N/A N/A | DYNAVAX TECHNOLOGIES CORP | DVAX | Sun Elaine D Director | 0 | $0 | 0 (Direct) | View |
| 2021-04-01 Tax Withholding | 2021-04-01 7:43 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Sun Elaine D SVP, Chief Financial Officer | 4,059 | $42.43 | 44,618 (Direct) | View |
| 2021-04-01 Exercise | 2021-04-01 7:43 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Sun Elaine D SVP, Chief Financial Officer | 10,196 | $0 | 44,618 (Direct) | View |
| 2021-03-02 Exercise | 2021-03-02 7:15 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Sun Elaine D SVP, Chief Financial Officer | 12,166 | $0 | 44,377 (Direct) | View |
| 2021-03-02 Tax Withholding | 2021-03-02 7:15 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Sun Elaine D SVP, Chief Financial Officer | 4,285 | $45.01 | 44,377 (Direct) | View |
| 2021-02-15 Option Award | 2021-02-17 5:03 pm | 2022-02-15 2031-02-15 | HALOZYME THERAPEUTICS INC. | HALO | Sun Elaine D SVP, Chief Financial Officer | 40,540 | $0 | 40,540 (Direct) | View |
| 2020-04-01 Option Award | 2020-04-03 4:56 pm | 2021-04-01 N/A | HALOZYME THERAPEUTICS INC. | HALO | Sun Elaine D SVP, Chief Financial Officer | 40,796 | $0 | 40,796 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 4:03 pm | 2021-03-02 2030-03-02 | HALOZYME THERAPEUTICS INC. | HALO | Sun Elaine D SVP, Chief Financial Officer | 153,631 | $0 | 153,631 (Direct) | View |